Association between physical activity and risk of hospitalisation in bronchiectasis.

Victoria Alcaraz-Serrano, Elena Gimeno-Santos, Giulia Scioscia, Albert Gabarrús, Adria Navarro, Beatriz Herrero-Cortina, Rosanel Amaro, Laia Fernández-Barat, Antoni Torres

Journal: The European respiratory journal 2021;55(6):1902138

PMID: 32184321

Abstract

BACKGROUND

Patients with bronchiectasis have a less active lifestyle than healthy peers, but the association with hospital admission has not been explored. The aim of this study was to investigate the association between 1) any physical activity variable; and 2) sedentary time, with hospitalisation due to exacerbation in adults with bronchiectasis.

METHODS

In this prospective observational study, baseline lung function, quality of life, exercise tolerance, severity of bronchiectasis and physical activity were recorded. Physical activity was objectively assessed over a week using a SenseWear armband and the results were expressed in steps·day and sedentary time. Number of hospitalisations due to a bronchiectasis exacerbation and time to first event were recorded after 1-year follow-up.

RESULTS

Sixty-four patients with bronchiectasis were analysed, of whom 15 (23%) were hospitalised during the follow-up. Hospitalised patients showed poor baseline clinical and severity outcomes, fewer steps walked per day and more sedentary behaviour than the non-hospitalised group. Patients who walked ≤6290 steps·day or spent ≥7.8 h·day in sedentary behaviour had an increased risk of hospital admission due to bronchiectasis exacerbation at 1-year follow-up. Specifically, ≥7.8 h·day of sedentary behaviour was associated with a 5.9-fold higher risk of hospital admission in the following year.

CONCLUSIONS

Low levels of physical activity and high sedentary time at baseline were associated with a higher risk of hospitalisation due to bronchiectasis exacerbation. If these findings are validated in future studies, it might be appropriate to include physical activity and sedentary behaviour as an item in severity scores.

Copyright ©ERS 2020.

Address: Fundació Clínic per la Recerca Biomèdica (FCRB), CIBERES, Hospital Clinic de Barcelona, Barcelona, Spain.; Both authors contributed equally to this work.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain [email protected].; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Both authors contributed equally to this work.; Institute of Respiratory Diseases, Dept of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.; Fundació Clínic per la Recerca Biomèdica (FCRB), CIBERES, Hospital Clinic de Barcelona, Barcelona, Spain.; Vitruvi Centre de Biosalut, Barcelona, Spain.; Universidad San Jorge, Zaragoza, Spain.; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.; Institut Clínic Respiratori, Hospital Clínic de Barcelona, Barcelona, Spain.; Fundació Clínic per la Recerca Biomèdica (FCRB), CIBERES, Hospital Clinic de Barcelona, Barcelona, Spain.; Institut Clínic Respiratori, Hospital Clínic de Barcelona, Barcelona, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.